Categories Earnings, Other Industries

Cintas (CTAS) hikes dividend, changes payout policy

Cintas Corporation (NASDAQ: CTAS), a leading provider of corporate uniforms, has raised its annual dividend by 10% and changed its payout policy to a quarterly basis.

The company has stayed largely resilient to the COVID crisis so far. Recently, it reported an increase in second-quarter earnings, which also exceeded estimates, bringing cheer to shareholders.

Earnings per share increased to $2.62 from $2.27 in the second quarter of last year. Net income was $284.9 million, up 15.7% from the year-ago quarter. Revenues, meanwhile, decreased 4.7% to $1.76 billion and missed the estimates.

The company declared an annual dividend of $2.81 per share, which represents a 10.2 % rise from last year. It also changed the payout policy to a quarterly-basis from an annual payout. Analysts have upgraded their consensus estimate on the company’s earnings regularly, suggesting an improvement in sentiment around its earnings potential next year.


Read management/analysis’ comments on quarterly results


Shares of Cintas have gained about 30% in the past six months. They closed the last trading session down 2%.

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731

Key takeaways from Visa’s Q3 2024 earnings report

Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in

Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024

Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top